Table 2 Prior reports of IMN in pediatric patients: a comparative review
Author, Year | N | Follow-up Period (yr) | Mean Age at Presentation (yr) | Age Range | M:F | Nephrotic at Presentation (%) | ↓ GFR at last F/U (%) | HTN at last F/U (%) | Estimated Occurrence Rate (%) |
|---|---|---|---|---|---|---|---|---|---|
Habib et al., 1973 | 50 | 1–10 | NA | 8 mo-14 yr | 38:12 | 62 | 10 | NA | 3.7 |
Trainin et al., 1976 | 14 | 5.5 | 9 | 2–15 yr | 6:8 | 79 | 29 | NA | 6.7 |
Ramirez et al., 1982 | 22 | 4.7 | 12 | 11 mo-19.9 yr | 11:11 | 77 | 37 | NA | 5.7 |
Latham et al., 1982 | 14 | 6.4 | 10.5 | 3.5–14 | 9:5 | 79 | 21 | NA | 1.3 |
Tsukahara et al., 1993 | 12 | 5.9 | 7.7 | 2.9–15.8 yr | 8:4 | 25 | 0 | 0 | 3 |
Obana et al., 2006 | 38 | 7.5 (SMGN); 12.4 (GMGN) | 7.6 | 1.5–16 yr | 25:13 | 24 | 0 | 5% | 2.4 |
Lee et al., 2006 | 19 | 28.5 | 9.5 | 1.7–14.9 | 9:10 | 89.5 | 15 | NA | 1 |
Current study | 13 | 3.5 | 9.6 | 4–17 yr | 6:7 | 38 | 23 | 54% | 2.8 |